Loading...
XNYS
DGX
Market cap19bUSD
Mar 10, Last price  
173.12USD
1D
-1.39%
1Q
9.25%
Jan 2017
88.38%
Name

Quest Diagnostics Inc

Chart & Performance

D1W1MN
XNYS:DGX chart
P/E
22.50
P/S
2.08
EPS
7.70
Div Yield, %
1.71%
Shrs. gr., 5y
-4.06%
Rev. gr., 5y
4.20%
Revenues
9.25b
-6.38%
5,126,601,0005,503,711,0006,268,659,0006,704,907,0007,249,400,0007,455,200,0007,368,900,0007,510,500,0007,382,600,0007,146,000,0007,435,000,0007,493,000,0007,515,000,0007,709,000,0007,531,000,0007,726,000,0009,437,000,00010,788,000,0009,883,000,0009,252,000,000
Net income
854m
-9.73%
499,195,000546,277,000586,421,000339,939,000581,500,000729,100,000720,900,000470,600,000555,700,000849,000,000556,000,000709,000,000645,000,000772,000,000736,000,000858,000,0001,431,000,0001,995,000,000946,000,000854,000,000
CFO
1.27b
-25.96%
798,780,000851,583,000951,896,000926,924,0001,063,100,000997,400,0001,118,000,000895,500,0001,187,100,000652,000,000938,000,000810,000,0001,069,000,0001,175,000,0001,200,000,0001,243,000,0002,005,000,0002,233,000,0001,718,000,0001,272,000,000
Dividend
Apr 07, 20250.8 USD/sh
Earnings
Apr 21, 2025

Profile

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
URL
https://www.questdiagnostics.com/
IPO date
Dec 17, 1996
Employees
40,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
9,252,000
-6.38%
9,883,000
-8.39%
Cost of revenue
6,291,000
6,450,000
Unusual Expense (Income)
NOPBT
2,961,000
3,433,000
NOPBT Margin
32.00%
34.74%
Operating Taxes
248,000
264,000
Tax Rate
8.38%
7.69%
NOPAT
2,713,000
3,169,000
Net income
854,000
-9.73%
946,000
-52.58%
Dividends
(314,000)
(305,000)
Dividend yield
2.02%
1.65%
Proceeds from repurchase of equity
(275,000)
(1,285,000)
BB yield
1.77%
6.96%
Debt
Debt current
456,000
155,000
Long-term debt
5,569,000
5,109,000
Deferred revenue
(295,000)
Other long-term liabilities
876,000
812,000
Net debt
5,204,000
4,817,000
Cash flow
Cash from operating activities
1,272,000
1,718,000
CAPEX
(408,000)
(404,000)
Cash from investing activities
(1,061,000)
(543,000)
Cash from financing activities
160,000
(1,732,000)
FCF
2,248,000
3,204,000
Balance
Cash
686,000
315,000
Long term investments
135,000
132,000
Excess cash
358,400
Stockholders' equity
8,924,000
8,385,000
Invested Capital
12,562,600
11,144,000
ROIC
22.89%
28.32%
ROCE
22.92%
30.01%
EV
Common stock shares outstanding
113,000
118,000
Price
137.88
-11.86%
156.44
-9.58%
Market cap
15,580,440
-15.60%
18,459,920
-16.64%
EV
20,895,440
23,390,920
EBITDA
3,400,000
3,870,000
EV/EBITDA
6.15
6.04
Interest
163,000
138,000
Interest/NOPBT
5.50%
4.02%